Drug Approval | April 24, 2023
Zydus receives final approval from the USFDA for Icosapent Ethyl Capsules
Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels
Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels
The USFDA had classified the inspection as "Official Action Indicated" (OAI).
Aji Bio-Pharma has six fill finish lines located in San Diego, including a new line
Fully equipped labs with 75-member team set-up and made operational in <100 days
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
Gafchromic films support patient care in oncology
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Metoprolol is used with or without other medications to treat high blood pressure (hypertension).
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
Subscribe To Our Newsletter & Stay Updated
